Your Psychedelic Therapy Training Begins With Us
Choose Your Program
Psychedelic-Assisted Therapy Courses and Programs
Globally renowned leaders in the health and wellness community have partnered with ATMA to develop the curricula, training models, and lectures for our psychedelic therapy program and course offerings.
Introduction to Psychedelic-assisted Therapy (PaT) Course
This CE credited course offers an overview of psychedelic medicines in a convenient manner, allowing for healthcare providers to gain familiarity with psychedelic therapy medicine.
Advanced Psychedelic-assisted Therapy (PaT) Certification Program
This program will provide the opportunity for legal experiential training under the supervision of skilled psychedelic guides and medical practitioners.
Physicians and Prescribers Course
This is a CME eligible course for physicians, psychiatrists, and prescribers. It is important for prescribers to have knowledge, backed by science, to properly assess patients for psychedelic treatments.
In-person training, cross-participation in Health Canada clinical trials are available with the Advanced PaT Certification Program and Physicians & Prescribers Course.
Psilocybin In-person Training with Clinical Trial Participation
This training curriculum is included in ATMA’s Advance PaT Certification program but also accessible to international students that have graduated from advance training programs such as MAPS, CIIS, Fluence and other advance qualifying programs.
MDMA In-person Training with Clinical Trial Participation
The details of the MDMA In-person training and curriculum will be made available upon Health Canada approval of ATMA’s N500 MDMA Clinical Trial Application.
Student Success Story
Study with Like-Minded Healthcare Professionals
Choose Your Program
Understanding Your Role in Psychedelic-Assisted Therapy
Safe and effective psychedelic-assisted therapy requires a care team that’s been trained for their role in psychedelic-assisted therapy. We offer several programs that can equip you for your specific role in psychedelic therapy.
Introduction to PaT Course
Advanced PaT Certification Program
Physicians & Prescribers PaT Course
Clinical Trial Participation
Introduction to Psychedelic-Assisted Therapy Course
If you are interested in taking the first step to being involved in psychedelic-assisted therapy please sign up for the Introduction to Psychedelic-Assisted Therapy Course.
Whatever your current role is in providing healthcare or counseling to clients or patients, whether you are a healthcare professional or just thinking about working in this field, whether you work in the public or private sector, if you are interested in psychedelic-assisted therapy, this course is a great place to start for you. With this course you will learn enough about psychedelic-assisted therapy to be able to confidently answer clients/patients questions and have in-depth conversations with peers.
You will be part of ATMA’s community after taking this course, and be kept up to date on developing regulations where you live and practice. You will be able to engage with peers going through our clinical trials as well as those offering psychedelic-assisted therapy starting this year. Keep in the loop so you can find where your talent and expertise can be applied when psychedelic-assisted therapy is legal in your jurisdiction.
Advanced Psychedelic-Assisted Therapy Certification Program
If you are interested in adding psychedelic-assisted therapy to your practice, please sign up for our Advanced PaT Certification Program*
*Please note that the Introduction to PaT Course is a requirement for the Advanced PaT Certification Program
As an appropriately trained healthcare provider, you already have substantial education and supervised practice. The focus of ATMA’s training programs is on the applications and intricacies of using psychedelic medicines as a therapeutic tool. Rather than training therapists to be therapists, ATMA works with therapists and aspiring psychedelic guides alike to develop competencies specific to the use of psychedelic medicines in mental health treatment.
Physicians & Prescribers PaT Course
If you are a doctor, prescriber or psychiatrist who will be prescribing psychedelics, or simply wants to learn more about them, please sign up for our Physicians & Prescribers Course.
Physicians will play a key role in psychedelic-assisted psychotherapy. Like all drugs in consideration for public accessibility, safety becomes the overarching concern for regulators and consumers alike. While physicians and prescribers generally do not provide direct mental health therapy or provide psychedelic prescriptions, doctors will need to participate in the psychedelic revolution to ensure this effective and revolutionary treatment is safely delivered to the public.
In-person Training and Clinical Trial Participation
If you would like to participate in an MDMA or psilocybin clinical trials (must meet eligibility criteria), please sign up for our Advanced PaT Certification Program to obtain one of the key eligibility requirements.
We are working with Health Canada and other partners to conduct multiple clinical trials evaluating the safety and efficacy of psilocybin and MDMA in therapy settings.
Clinical trials are available for registered frontline healthcare workers who have completed an approved psychedelic-therapy training program, similar to ATMA’s training programs.
Objections & FAQs
Psychedelic-Assisted Therapy Program and Courses FAQs
The Introduction to PaT course is entirely online with live Q&A.
The Advanced PaT Certification Program offers online training as well as in-person, and an opportunity to participate in our clinical trial.
The Physician & Prescriber PaT course is entirely online with live Q&A.
We have partnered with clinics across Canada to provide in-person experiential training and clinical trial participation in BC, Alberta and Ontario. If you are unable or unwilling to partake in the in-person training, you can enroll in our Advance PaT Certification Program online portion only where no in-person training is required.
Yes! Our psychedelic-assisted therapy programs are online and available to those in the United States and Australia who wish to receive training in psychedelic-assisted therapy.
We do offer exceptions for the Introduction Program for those who qualify. Please contact us to learn more.
Newsletter signup
Speak to a Program Advisor
Do you have questions about psychedelic-assisted therapy training, aren’t sure what course is right for you, or want to talk to an advisor? Contact us with the form and we’ll be in touch right away.
ATMA needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at anytime. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.
Why ATMA?
Demand for Psychedelic-Assisted Therapy Providers is Growing
The demand for quality education and training programs in psychedelic-assisted therapy will outstrip the supply available very quickly as Oregon and Australia prepare for legalization under very different regulations in 2023. There simply isn’t an ability to train that many therapy providers and prescribers as fast as clients will be seeking services. This surge of demand will create a bottleneck as service providers scramble to find available training. ATMA is working to make training available in a timely manner but we urge those interested to begin now and not wait till the bottleneck occurs.
Our programs and platform will fully prepare mental healthcare professionals, especially those in Australia, British Columbia, Alberta, Oregon, California, Washington, Idaho, and Nevada who can begin their education and training now, to begin practicing legal psilocybin-assisted therapy as early as this year, under Oregon’s legal Psilocybin Services and Australia’s legalization of MDMA and psilocybin therapy.
